Nevertheless, even if unadjusted pool estimations showed a trend toward better ORR outcomes among patients who received either NMA or post-infusional IL2, multivariate model did not demonstrate any higher likelihood of tumor response in these subsets.
← all excerpts
Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis.
1
—
—